- Filed
- May 14, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 14, 2024 | 2.86M sh |
| Stock Repurchased | Q1 2024 · Mar 31, 2024 | $0 |
| Stock Repurchased | Q1 2024 · Mar 31, 2023 | $1K |
| Capex | Q1 2024 · Mar 31, 2024 | $0 |
| Capex | Q1 2024 · Mar 31, 2023 | $40K |
| Short Term Investments | Q1 2024 · Mar 31, 2024 | $4.33M |
| Short Term Investments | Q1 2024 · Dec 31, 2023 | $4.37M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $32.44M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $32.44M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $14.12M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $9.48M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $46.48M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $41.9M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $10.25M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2023 | $9.35M |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 2.87M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $10.84M |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | −$0.28 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$0.28 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $2.81M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$799K |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $1.74M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $206K |
| Revenue | Q1 2024 · Mar 31, 2023 | $1.94M |